Overview
- Rocket Lab has not flown Neutron and CEO Peter Beck has said the company’s year‑end window for a maiden flight is narrowing, making the vehicle the central operational risk for the business.
- Company guidance ties a clear financial inflection to Neutron: management says adjusted EBITDA should turn positive in the quarter after a successful test flight and that free cash flow could improve roughly 18 to 24 months after that event.
- The business behind that projection is growing today — Q2 revenue rose about 62% year over year to roughly $234 million and backlog reached a record $2.36 billion, including recent large U.S. defense awards.
- Rocket Lab is spending heavily to finish Neutron and to fund acquisitions and the pending roughly $8 billion Iridium deal; roughly $1.08 billion of recent equity proceeds is earmarked for those strategic transactions, leaving tighter operational liquidity.
- Market sentiment has swung: shares sit in the low‑to‑mid $60s after a >50% fall from spring highs, Cathie Wood’s ARK bought about 705,000 shares (~$44 million), analysts still see upside if Neutron succeeds, and a NASA Mars telecom award to Blue Origin was a near‑term setback for Rocket Lab.